Motixafortide Acetate Patent Expiration

Motixafortide Acetate was first introduced by Ayrmid Pharma Ltd in its drug Aphexda on Sep 8, 2023.


Motixafortide Acetate Patents

Given below is the list of patents protecting Motixafortide Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Aphexda US12257285 Composition of BL-8040 Dec 29, 2041 Ayrmid Pharma
Aphexda US12268725 Composition of BL-8040 Dec 29, 2041 Ayrmid Pharma



Motixafortide Acetate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List